SM
Satya Murali Krishna Kammila
About Satya Murali Krishna Kammila
Data last updated:
Satya Murali Krishna Kammila is a Director at Sai Sridhar Pharma Private Limited (since 2021), Director at Sidson Pharma Distributors Private Limited (since 2021) and Director at Deccan Medisales Private Limited (since 2021), and holds 7 more current directorships. The companies operate in Pharma, Consumer Electronics & Durables and Financial Services. The 9 current companies with reported revenue have a combined latest revenue of ₹655 Cr; the largest is Sai Sridhar Pharma Private Limited at ₹349 Cr (FY 2025). Earlier, Satya Murali Krishna Kammila was a Whole-Time Director at Optival Health Solutions Private Limited (2007–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sai Sridhar Pharma Private Limited U24232TG2007PTC055902 | Director | 29 Sep 2021 | 2007 | ₹349 Cr (FY 2025) | Active |
| Sidson Pharma Distributors Private Limited U74900TG2014PTC092145 | Director | 29 Sep 2021 | 2014 | ₹140 Cr (FY 2025) | Active |
| Deccan Medisales Private Limited U51397KA2011PTC059204 | Director | 29 Sep 2021 | 2011 | ₹128 Cr (FY 2025) | Active |
| Dureleg Manufacturing Private Limited U19116TG2013PTC091980 | Director | 05 Nov 2024 | 2013 | ₹23.95 Cr (FY 2025) | Active |
| Wynclark Pharmaceuticals Private Limited U24239TG2007PTC052676 | Whole-Time Director | 29 Sep 2021 | 2007 | ₹13.13 Cr (FY 2025) | Active |
| Medplus Insurance Brokers Private Limited U67100TG2022PTC164765 | Director | 14 Jul 2022 | 2022 | ₹1.16 Cr (FY 2025) | Active |
| Nova Sud Pharmaceuticals Private Limited U24232TG2007PTC055895 | Director | 29 Sep 2021 | 2007 | ₹12.7 Lakh (FY 2025) | Active |
 Kalyani Meditimes Private Limited U74999TN2016PTC111701 | Director | 29 Sep 2021 | 2016 | ₹3.7 Lakh (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Optival Health Solutions Private Limited U85110TG2005PTC046821 | Whole-Time Director | 30 Jan 2007 | 2005 | ₹6,059 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satya Murali Krishna Kammila
| Name | DIN | Company | Designation |
|---|---|---|---|
| Paidiwar Srinivas | 00898824 | Sai Sridhar Pharma Private Limited , Sidson Pharma Distributors Private Limited and 7 more | Director |
| Phani Srinivas Ramella | 03273162 | Sai Sridhar Pharma Private Limited , Sidson Pharma Distributors Private Limited and 4 more | Director |
| Udaya Lakshmi Tadepalli | 06976534 | Sai Sridhar Pharma Private Limited | Additional Director |
| Bhaskar Reddy Cherukupalli | 00926550 | Wynclark Pharmaceuticals Private Limited , Nova Sud Pharmaceuticals Private Limited and 2 more | Director |
| Riti Gupta | Wynclark Pharmaceuticals Private Limited | Company Secretary | |
| Ritik Jain | Wynclark Pharmaceuticals Private Limited | Company Secretary | |
| Sujit Kumar Mahato | 07599067 | Wynclark Pharmaceuticals Private Limited | Cfo |
| Sujit Kumar Mahato | Wynclark Pharmaceuticals Private Limited | Cfo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satya Murali Krishna Kammila
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satya Murali Krishna Kammila
Satya Murali Krishna Kammila currently holds 10 directorships: Sai Sridhar Pharma Private Limited (Director, since 29 Sep 2021, revenue ₹349 Cr (FY 2025)); Sidson Pharma Distributors Private Limited (Director, since 29 Sep 2021, revenue ₹140 Cr (FY 2025)); Deccan Medisales Private Limited (Director, since 29 Sep 2021, revenue ₹128 Cr (FY 2025)); Dureleg Manufacturing Private Limited (Director, since 05 Nov 2024, revenue ₹23.95 Cr (FY 2025)); Wynclark Pharmaceuticals Private Limited (Whole-Time Director, since 29 Sep 2021, revenue ₹13.13 Cr (FY 2025)); and 5 more.
Satya Murali Krishna Kammila was first appointed on 30 Jan 2007 as Whole-Time Director at Optival Health Solutions Private Limited. The most recent appointment on record is 05 Nov 2024 at Dureleg Manufacturing Private Limited.
The 9 current companies of Satya Murali Krishna Kammila that report revenue have a combined latest revenue of ₹655 Cr: Sai Sridhar Pharma Private Limited ₹349 Cr (FY 2025); Sidson Pharma Distributors Private Limited ₹140 Cr (FY 2025); Deccan Medisales Private Limited ₹128 Cr (FY 2025); Dureleg Manufacturing Private Limited ₹23.95 Cr (FY 2025); Wynclark Pharmaceuticals Private Limited ₹13.13 Cr (FY 2025); and 4 more.
Satya Murali Krishna Kammila held 1 earlier board appointment: Optival Health Solutions Private Limited (Whole-Time Director, 30 Jan 2007 to 14 Feb 2022).
The current boards of Satya Murali Krishna Kammila's companies include Paidiwar Srinivas (Sai Sridhar Pharma Private Limited), Phani Srinivas Ramella (Sai Sridhar Pharma Private Limited), Udaya Lakshmi Tadepalli (Sai Sridhar Pharma Private Limited), Bhaskar Reddy Cherukupalli (Wynclark Pharmaceuticals Private Limited), Riti Gupta (Wynclark Pharmaceuticals Private Limited), Ritik Jain (Wynclark Pharmaceuticals Private Limited), among others.